Dr. Fredric Manfredsson, Ph.D.

Associate Professor
Department of Translational Neuroscience
Barrow Neurological Institute

Dr. Manfredsson is a distinguished expert in the molecular neuroscience, with a focused interest in gene therapy for Parkinson's disease and other neurodegenerative disorders. As a member of several prominent organizations, including the American Society for Gene & Cell Therapy and the Society for Neuroscience, he is at the forefront of innovative research. Dr. Manfredsson earned a doctorate in neuroscience from the University of Florida, where he also completed a postdoctoral fellowship. Dr. Manfredsson’s research primarily centers on understanding the role of the protein alpha-synuclein, which is crucial in both healthy cells and those impacted by Parkinson's disease. His work aims to unravel the complexities of this protein to pave the way for advanced therapeutic strategies that could significantly benefit patients suffering from Parkinson's disease and associated debilitating conditions.

Head of Research Initiatives

The Future

As part of our effort to bridge gaps across research studies, we are providing a platform for data integration. By collecting and analyzing data from main text and supplemental tables presenting genetic, transcriptomic, and proteomic research findings, we are developing a series of comprehensive tables that allow for unbiased comparison. Currently, the focus is on not re-analyzing data, but presenting findings with detailed documentation of methods. Utilizing this resource, scientists can better identify high-yield avenues for Parkinson's disease research, facilitating development of better targeted therapeutic strategies. These tables serve as a critical tools in the study of Parkinson's disease neurodegenerative processes, paving the way for advancements in diagnosis and treatment. As our understanding of molecular mechanisms advances, so too does the potential for improved outcomes for individuals living with Parkinson's disease.